Company / Shares Outstanding
Dianthus Therapeutics, Inc. /DE/ Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
31.1M
FY2025
5-year range
874.2K / 54.9M
FY2021-FY2025
Trend
+110.0%
vs FY2024
Sector context
#192 of 212
Health Care
What the data says
Among 212 Health Care companies, Dianthus Therapeutics, Inc. /DE/ is in the top 9% for shares outstanding. Shares Outstanding has increased for 3 consecutive years, from 874234.00 in FY2022 to 31115341.00 in FY2025.
Based on SEC 10-K filings.
31115341.00 in FY2025 with a 5-year CAGR of -6.7%.
Increased from 5153423.00 to 31115341.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +228.9%
- 5-Year CAGR
- -6.7%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 212This company 31.1M Sector average 306.0M
▼
-89.8% below sector average
Key checks
Key Insights
- Dianthus Therapeutics, Inc. /DE/'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 110.0% year-over-year.
- Ranks #192 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 31.1M | +110.0% |
| FY2024 | 14.8M | +187.5% |
| FY2023 | 5.2M | +489.5% |
| FY2022 | 874.2K | -98.4% |
| FY2021 | 54.9M | +25.1% |
| FY2020 | 43.9M | +31.9% |
| FY2019 | 33.3M | +1316.5% |
| FY2018 | 2.4M | +26.6% |
| FY2017 | 1.9M | +1142.8% |
| FY2016 | 149.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026